Wolfgang Leitner | |
---|---|
Born | 27 March 1953 |
Nationality | Austrian |
Education | University of Graz |
Title | CEO, Andritz AG |
Term | 1994-2022 |
Children | 2 |
Wolfgang Leitner (born 27 March 1953) [1] is an Austrian billionaire and former CEO of Andritz AG, an Austrian plant engineering company. [2]
Leitner was born in 1953 in Graz, Austria. His father was a metal worker at Andritz AG. [2] In 1978, Leitner received a doctorate in chemistry [3] from the University of Graz. [1]
After university Leitner worked in research for Vianova, an Austrian subsidiary of Hoechst AG. In 1981, he started working as a management consultant for McKinsey. In 1986, he founded the pharmaceutical company Genericon Pharma [3] together with his former classmate Martin Bartenstein, who would later become a mininister in the Austrian government. Genericon Pharma’s Hungarian subsidiary Pharmavit achieved great success with effervescent tablets and generic drugs. [1] In 1995, the company was bought by the US pharmaceutical group Bristol Myers Squibb for USD 110 million. [2] [4]
Leitner joined Andritz AG as chief financial officer in 1987. In 1994, he became chief executive officer. [3] In 1999, when Andritz AG was sold, Leitner acquired a 26 percent stake. [2] In July 2021, Joachim Schönbeck was appointed as Leitner's successor as CEO of Andritz AG starting in April 2022. Leitner subsequently moved to the supervisory board. [4] [5]
Leitner is married, with two children, and lives in Graz, Austria. [2]
Leitner made the 2024 Forbes Billionaires List with an estimated wealth of US$ 2.7 billion, the sixth richest in Austria and 1238th richest person in the world. [6]